Research Topics
| James NeubergerSummaryAffiliation: Birmingham Heartlands Hospital Country: UK Publications
| Collaborators
|
Detail Information
Publications
Transplantation for alcoholic liver diseaseJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
J Hepatol 36:130-7. 2002
Impact factors: uses and abusesJames Neuberger
Research and Development Directorate, Queen Elizabeth Hospital, Birmingham, UK
Eur J Gastroenterol Hepatol 14:209-11. 2002..Like all measures, the use of Impact Factors has to be tempered with knowledge of their limitations and common sense used in interpreting any data based on any analysis...
A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allograftsEdward Alabraba
Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Liver Transpl 15:330-40. 2009..Moreover, we have shown that EDC grafts are also a significant risk factor for rPSC...
Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failureEd Day
University of Birmingham Department of Psychiatry, Queen Elizabeth Psychiatric Hospital, Birmingham, UK
Liver Transpl 14:1609-13. 2008..These findings point to the need to take an adequate history of lifetime alcohol problems in all patients being considered for liver transplantation...
Conditional organ donation: case scenarios and questionsJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Transplantation 85:1527-9. 2008
Transplantation in autoimmune liver diseasesMarcus Mottershead
Queen Elizabeth Hospital, Birmingham B15 2TH, UK
World J Gastroenterol 14:3388-95. 2008..For autoimmune diseases, transplantation is associated with significant improvement in the quality and length of life. Disease may recur after transplantation and may affect patient and graft survival...
Transplantation for alcoholic liver disease: report of a consensus meetingKerry Webb
Liver Unit, University Hospitals, Birmingham, United Kingdom
Liver Transpl 12:301-5. 2006
Predictors of psychological morbidity in liver transplant assessment candidates: is alcohol abuse or dependence a factor?Ed Day
Department of Psychiatry, University of Birmingham, Birmingham, UK
Transpl Int 22:606-14. 2009..Higher rates of psychological distress were associated with greater severity of liver disease, being unemployed, and being a tobacco smoker. Possible reasons for these findings and potential future management strategies are discussed...
Recurrent nonviral liver disease following liver transplantationKa Kit Li
Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
Expert Rev Gastroenterol Hepatol 3:257-68. 2009..Finally, an understanding of which diseases do recur after transplantation and identification of the risk factors may lead to a better understanding of the pathogenetic mechanisms of these conditions...
Late protocol liver biopsies in the liver allograft: a neglected investigation?George Mells
Liver Unit, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Liver Transpl 15:931-8. 2009..Liver Transpl 15:931-938, 2009. (c) 2009 AASLD...
The impact of disease recurrence on graft survival following liver transplantation: a single centre experienceIan A Rowe
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Transpl Int 21:459-65. 2008..Disease recurrence is a significant cause of graft loss particularly in HCV, PSC and AIH. Recurrent disease, in part, explains the increased overall risk of graft loss in these groups...
Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent diseaseDhiraj Tripathi
Liver Unit, University Hospital Birmingham, NHS Foundation Trust, Birmingham B15 2TH, United Kingdom
Semin Liver Dis 29:286-96. 2009..There remains controversy over the role for protocol liver biopsies to detect recurrent disease and the best immunosuppressive strategies to prevent and treat recurrence...
Public and professional attitudes to transplanting alcoholic patientsJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Liver Transpl 13:S65-8. 2007..Public education is required to demonstrate that patients with ALD are carefully selected for liver transplantation and available grafts are used with attention to equity, justice, and utility...
Illicit drug use and liver transplantation: is there a problem and what is the solution?Kerry Webb
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Transpl Int 21:923-9. 2008..UK guidelines on assessment and selection have been agreed. Careful assessment and access to treatment should be considered...
Weight gain and obesity after liver transplantationJames Richards
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Transpl Int 18:461-6. 2005..The greatest weight gain occurs after the first 6 months and intervention with dietary advice at this point could be implemented to minimize the long-term morbidity and mortality risks associated with obesity...
Liver transplantation for primary biliary cirrhosisGerry C MacQuillan
Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH England, UK
Clin Liver Dis 7:941-56, ix. 2003..Following transplantation, antimitochondrial antibodies persist and histological features of recurrent PBC may be seen in the allograft in up to 50% by 10 years; however, at least in the medium-term, this rarely causes clinical problems...
Chronic allograft dysfunction: diagnosis and management. Is it always progressive?James Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
Liver Transpl 11:S63-8. 2005..5. Treatment is of the underlying cause but some, such as recurrent and de novo autoimmune hepatitis and recurrent primary sclerosing cholangitis may not respond well, and regraft may be required...
Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantationIlaria Lenci
Liver Unit, Queen Elizabeth University Hospital, Birmingham, UK
J Am Soc Echocardiogr 22:89-94. 2009....
Conditional organ donation: the views of the UK general public findings of an Ipsos-Mori PollJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Transplantation 85:1545-7. 2008
Treatment of hepatitis C virus infection in the allograftJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, England
Liver Transpl 9:S101-8. 2003..Side-effects of treatment are common and reduction/withdrawal is frequent, but the regime is cost-effective. 7. The role of newer treatments remains to be established...
The management of patients awaiting liver transplantationKa Kit Li
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Nat Rev Gastroenterol Hepatol 6:648-59. 2009....
Recurrence of nonviral diseasesYe Htun Oo
Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, United Kingdom
Clin Liver Dis 11:377-95. 2007..This article discusses the recurrence of nonviral diseases after liver transplantation, diagnosis, and management...
Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?Tim C M A Schreuder
Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
Transpl Int 22:144-52. 2009..Risk factors for rPBC include use of tacrolimus compared with cyclosporine; for rPSC include absence of colon peri-transplantation and for rAIH possible associations with some HLA haplotypes have been suggested...
Options for treatment of primary biliary cirrhosisYe H Oo
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Drugs 64:2261-71. 2004..For those who are intolerant of the drug or where it is ineffective, rifampicin and naltrexone may be effective. There is no effective treatment for the associated lethargy...
Should liver transplantation be made available to everyone? The case againstJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, England
Arch Intern Med 163:1881-3; discussion 1885-6. 2003
Living liver donation: a survey of the attitudes of the public in Great BritainJames Neuberger
The Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom. J.M.Neuberger.ac.uk
Transplantation 76:1260-4. 2003..CONCLUSIONS: Most adults in Great Britain are in favor of LLD, although more than half believe that a donor risk of mortality of 1:200 is acceptable...
Liver transplantation in PBC and PSC: indications and disease recurrenceMarco Carbone
Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
Clin Res Hepatol Gastroenterol 35:446-54. 2011..The impact of recurrent disease on survival is unclear. Study of recurrent PBC and PSC may provide a better understanding of the mechanisms of these diseases in the native liver...
Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantationJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Liver Transpl 10:488-91. 2004..For those receiving cyclosporine, the median time to recurrence was 123 months and for those on tacrolimus 62 months (P <.001). Reasons for this difference between the 2 calcineurin inhibitors are not clear...
Liver transplantation for primary biliary cirrhosis: indications and risk of recurrenceJames Neuberger
Liver Unit, Queen Elizabeth Hospital, 3rd Floor, Nuffield House, Edgbaston, Birmingham B15 2TH, UK
J Hepatol 39:142-8. 2003
Conditional organ donation forum introductionJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
Transplantation 85:1526. 2008
DaclizumabMarcus Mottershead
Queen Elizabeth Hospital, Liver Unit, Birmingham, B15 2TH, UK
Expert Opin Biol Ther 7:1583-96. 2007..The agent is generally well tolerated in adults and children and there is no need for additional monitoring. Daclizumab has also been used outside the transplant arena in a variety of immune-mediated diseases with limited success...
Selfless adults and split donor liversJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
Lancet 370:299-300. 2007
Reducing the risks of cardiovascular disease in liver allograft recipientsGeorge Mells
Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
Transplantation 83:1141-50. 2007..If monotherapy is inadequate, ezetimibe or a fibrate may be added. Consideration may be given to change in immunosuppression if combination lipid-lowering therapy proves inadequate...
Role of living liver donation in the United KingdomJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH
BMJ 327:676-9. 2003
Self-organizing maps can determine outcome and match recipients and donors at orthotopic liver transplantationGeoffrey H Haydon
Liver Unit, Third Floor, Nuffield House, The Queen Elizabeth Hospital, Birmingham, UK
Transplantation 79:213-8. 2005..Ideally, to maximize the utility of those livers that are offered, donor and recipient characteristics should be matched to ensure the best possible posttransplant survival of the recipient...
Alternative medicines and the liverEdward Fogden
Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
Liver Int 23:213-20. 2003..Doctors need to be aware of the widespread use of CAM, ask their patients specifically regarding their use of CAM and be aware of the potential for hepatotoxicity and interactions...
Acute liver failure: bridging to transplant or recovery--are we there yet?Amit Singhal
The Liver Unit, Queen Elizabeth Hospital, Birmingham and University of Birmingham, UK
J Hepatol 46:557-64. 2007
Liver transplantation for primary biliary cirrhosisJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
Autoimmun Rev 2:1-7. 2003..Following transplantation, AMA persist and histological features of PBC may be seen in the allograft, in up to 50% by 10 years...
Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantationDevendra Desai
Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
Liver Transpl 9:754-9. 2003..Screening for MRSA should be considered in high-risk patients being assessed for liver transplantation...
Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitisAlonso Vera
Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham, England, United Kingdom
Transplantation 75:1983-8. 2003..We advocate long-term aggressive colonic surveillance and colectomy in selected high-risk patients with longstanding severe colitis...
Recurrent primary biliary cirrhosisJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
Liver Transpl 9:539-46. 2003..The diagnosis of recurrent PBC is made on the basis of a consistent history and demonstrating the histologic features of PBC on liver biopsy and exclusion of other causes of bile duct damage...
Risk factors for recurrence of primary sclerosing cholangitis of liver allograftAlonso Vera
Liver Unit, Queen Elizabeth Hospital, B15 2TH, Birmingham, UK
Lancet 360:1943-4. 2002..2, 95% CI 0.73-2.15) and an intact colon before transplantation (8.7, 1.19-64.48) were associated with recurrence. These observations could help elucidate the pathogenesis of the disease...
Transplantation for autoimmune hepatitisJames Neuberger
Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
Semin Liver Dis 22:379-86. 2002..Patients grafted for AIH tend to be at higher risk for both acute and chronic rejection. Withdrawal of immunosuppression is unlikely to be achieved...
Cardiovascular morbidity and mortality after orthotopic liver transplantationSimon D Johnston
Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
Transplantation 73:901-6. 2002....
First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantationGeorge Georgiou
Addictive Behaviours Centre, Birmingham, England
Liver Transpl 9:772-5. 2003..The intervention was readily integrated into the usual transplantation process and was acceptable to both patients and staff. Further research is required to clarify its impact on longer-term outcome measures...
Allocation of donor livers--is MELD enough?James Neuberger
Liver Transpl 10:908-10. 2004
Renal failure late after liver transplantationJames Neuberger
Liver Transpl 8:922-4. 2002
Protocol liver allograft biopsiesGeorge Mells
Transplantation 85:1686-92. 2008....
Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groupsLouise Longworth
Health Economics Research Group, Brunel University, Uxbridge, Middlesex, UK
Liver Transpl 9:1295-307. 2003..Cost-effectiveness estimates were poorer for patients with ALD over the 27-month period than for patients with PBC or PSC. This in part reflects the costs of the higher number of ALD patients assessed for each transplant...
Survival gain after liver transplantation for patients with alcoholic liver disease: a comparison across models and centersTracey A Young
Health Economics Research Group, Brunel University, Uxbridge, Middlesex UB8 3PH, UK
Transplantation 76:1479-86. 2003....
Transplantation for alcoholic liver diseaseKerry Webb
BMJ 329:63-4. 2004
Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message?George N Dalekos
Liver Int 28:426-8. 2008
Nutritional markers in liver allograft recipientsMohammad Shahid
St. Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary College, University of London, London, UK
Transplantation 79:359-62. 2005..29, P=0.04) and TSFT (rho=+0.25, P=0.02). CONCLUSIONS: These findings suggest that nutritional parameters and markers of disease severity do not correlate well with outcomes after transplantation...
HLA and outcome in living donor liver transplantation in primary biliary cirrhosis: a new piece in the jigsaw?Ye Htun Oo
Liver Transpl 13:8-13. 2007
Splitting livers - balancing the gain and the painDave Collett
UK Transplant, Stoke Gifford, Bristol, UK
Transpl Int 21:218-22. 2008..While this analysis is based on a number of assumptions, and so the results must be treated with caution, it does give rise to a number of ethical considerations which require open and public debate...
Grafts and hepatitis C virus: maximizing the benefitMarcus Mottershead
Liver Transpl 13:947-52. 2007
